This disclosure provides, for instance subset-optimized CART cells and related methods. For instance, the disclosure describes methods and compositions of CD4+ and CD8+ T cells that express CARs containing specific combinations of intracellular signaling domains can be used to increase persistence and anti-tumor activity of the infused CAR-expressing T cells for treating a subject having a disease, e.g., a cancer.
申请公布号
WO2016019300(A1)
申请公布日期
2016.02.04
申请号
WO2015US43219
申请日期
2015.07.31
申请人
NOVARTIS AG;THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA;JUNE, CARL, H.;GUEDAN CARRIO, SONIA;POSEY, AVERY D.;SCHOLLER, JOHN
发明人
JUNE, CARL, H.;GUEDAN CARRIO, SONIA;POSEY, AVERY D.;SCHOLLER, JOHN